| License: Creative Commons Attribution 3.0 (1MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-378943
- DOI to cite this document:
- 10.5283/epub.37894
Abstract
Glioblastoma remains a fatal diagnosis. Previous research has shown that metformin, which is an inhibitor of complex I of the respiratory chain, may inhibit some brain tumor initiating cells (BTICs), albeit at dosages that are too high for clinical use. Here, we explored whether a combined treatment of metformin and diclofenac, which is a non-steroidal anti-inflammatory drug (NSAID) shown to ...

Owner only: item control page